Inverse_JJ Association_NP of_IN Physical_NP Fitness_NP with_IN Plasma_NP Fibrinogen_NP Level_NP in_IN Children_NP The_NP Columbia_NP University_NP BioMarkers_NP Study_NP Carmen_NP R._NP Isasi1,2_NP ,_, Thomas_NP J._NP Starc3_NP ,_, Russell_NP P._NP Tracy4_NP ,_, Richard_NP Deckelbaum5_NP ,_, Lars_NP Berglund6_NP and_CC Steven_NP Shea1,2_NP 1_CD Division_NN of_IN General_NP Medicine_NP ,_, Department_NP of_IN Medicine_NP ,_, Columbia_NP University_NP College_NP of_IN Physicians_NPS and_CC Surgeons_NP ,_, New_NP York_NP ,_, NY_NP ._SENT 2_CD Division_NN of_IN Epidemiology_NP ,_, The_DT Joseph_NP Mailman_NP School_NP of_IN Public_NP Health_NP of_IN Columbia_NP University_NP ,_, New_NP York_NP ,_, NY_NP ._SENT 3_CD Division_NN of_IN Pediatric_NP Cardiology_NP ,_, Department_NP of_IN Pediatrics_NP ,_, Columbia_NP University_NP College_NP of_IN Physicians_NPS and_CC Surgeons_NP ,_, New_NP York_NP ,_, NY_NP ._SENT 4_CD Department_NP of_IN Pathology_NP and_CC Biochemistry_NP ,_, University_NP of_IN Vermont_NP ,_, Colchester_NP ,_, VT_NP ._SENT 5_CD Institute_NP of_IN Human_NP Nutrition_NP and_CC Department_NP of_IN Pediatrics_NP ,_, Columbia_NP University_NP ,_, New_NP York_NP ,_, NY_NP ._SENT 6_CD Division_NN of_IN Preventive_NP Medicine_NP and_CC Nutrition_NP ,_, Department_NP of_IN Medicine_NP ,_, Columbia_NP University_NP College_NP of_IN Physicians_NPS and_CC Surgeons_NP ,_, New_NP York_NP ,_, NY_NP ._SENT ABSTRACT_JJ TOP_NP ABSTRACT_NP INTRODUCTION_NP MATERIALS_NP AND_CC METHODS_NP RESULTS_NP DISCUSSION_NP REFERENCES_NP Plasma_NP fibrinogen_NN has_VBZ emerged_VBN as_IN a_DT risk_NN factor_NN for_IN cardiovascular_JJ disease_NN in_IN adults_NNS ,_, but_CC relatively_RB little_JJ is_VBZ known_VBN about_IN the_DT correlates_NNS of_IN plasma_NN fibrinogen_NN level_NN in_IN childhood_NN ._SENT In_IN the_DT Columbia_NP University_NP BioMarkers_NP Study_NP (_( 1994-1998_CD )_) ,_, the_DT authors_NNS evaluated_VBD the_DT association_NN between_IN physical_JJ fitness_NN and_CC plasma_NN fibrinogen_NN level_NN in_IN 193_CD children_NNS 4-25_CD years_NNS old_JJ ;_: 68_CD %_NN were_VBD Hispanic_JJ and_CC 46_CD %_NN male_NN ._SENT Fitness_NN level_NN assessed_VBN by_IN treadmill_NN testing_NN was_VBD inversely_RB associated_VBN with_IN plasma_NN fibrinogen_NN (_( r_LS =_SYM -0.24_CD ,_, p_NN <_SYM 0.001_CD )_) ._SENT Plasma_NN fibrinogen_NN levels_NNS showed_VBD a_DT graded_VBN inverse_JJ relation_NN with_IN tertiles_NNS of_IN fitness_NN assessed_VBN by_IN treadmill_NN (_( p_NN <_SYM 0.001_CD )_) ._SENT In_IN multivariate_JJ analyses_NNS ,_, after_IN adjustment_NN for_IN age_NN ,_, sex_NN ,_, race/ethnicity_NN ,_, body_NN mass_NN index_NN ,_, and_CC presence_NN of_IN the_DT A_NP allele_NN in_IN the_DT -455_CD position_NN of_IN the_DT ß-fibrinogen_NP promoter_NN gene_NN ,_, the_DT fitness_NN level_NN remained_VBD inversely_RB associated_VBN with_IN plasma_NN fibrinogen_NN level_NN (_( ß_NP =_SYM -1.3_CD ,_, 95_CD %_NN confidence_NN interval_NN (_( CI_NP )_) :_: -2.3_CD ,_, -0.34_CD )_) ._SENT Resting_JJ heart_NN rate_NN was_VBD also_RB correlated_VBN with_IN plasma_NN fibrinogen_NN level_NN (_( r_LS =_SYM 0.18_CD ,_, p_NN <_SYM 0.05_CD )_) ._SENT Fibrinogen_NN levels_NNS (_( mg/dl_NN )_) increased_VBN over_IN tertiles_NNS of_IN resting_JJ heart_NN rate_NN (_( p_NN =_SYM 0.002_CD )_) and_CC were_VBD significantly_RB associated_VBN with_IN resting_JJ heart_NN rate_NN in_IN multivariate_JJ analysis_NN (_( ß_NP =_SYM 0.82_CD ,_, 95_CD %_NN CI_NP :_: 0.17_CD ,_, 1.5_CD )_) ._SENT These_DT findings_NNS indicate_VBP that_IN plasma_NN fibrinogen_NN is_VBZ inversely_RB associated_VBN with_IN physical_JJ fitness_NN in_IN children_NNS independent_JJ of_IN body_NN mass_NN index_NN ._SENT Am_NP J_NP Epidemiol_NP 2000_CD ;_: 152:212-18_CD ._SENT body_NN mass_NN index_NN ;_: cardiovascular_JJ diseases_NNS ;_: fibrinogen_NN ;_: risk_NN factors_NNS Abbreviations_NNS :_: CI_NP ,_, confidence_NN interval_NN ;_: PWC[170_NP ]_SYM ,_, physical_JJ work_NN capacity_NN at_IN a_DT heart_NN rate_NN of_IN 170_CD beats_NNS per_IN minute_NN ;_: SD_NP ,_, standard_JJ deviation_NN ._SENT INTRODUCTION_NN TOP_NP ABSTRACT_NP INTRODUCTION_NP MATERIALS_NP AND_CC METHODS_NP RESULTS_NP DISCUSSION_NP REFERENCES_NP Based_VBN on_IN several_JJ cohort_NN studies_NNS (_( 1_CD Go_NP Go_NP Go_NP -4_NP Go_NP )_) ,_, plasma_NN fibrinogen_NN has_VBZ emerged_VBN as_IN a_DT new_JJ risk_NN factor_NN for_IN cardiovascular_JJ disease_NN in_IN adults_NNS ._SENT Arterial_JJ thrombosis_NN in_IN the_DT setting_NN of_IN plaque_NN rupture_NN plays_VBZ a_DT key_JJ role_NN in_IN triggering_VBG acute_JJ myocardial_JJ infarction_NN (_( 5_CD Go_NP )_) ._SENT The_DT protective_JJ role_NN of_IN physical_JJ activity_NN and_CC physical_JJ fitness_NN on_IN cardiovascular_JJ risk_NN factors_NNS has_VBZ been_VBN shown_VBN in_IN a_DT number_NN of_IN studies_NNS across_IN different_JJ populations_NNS ,_, in_IN both_DT adults_NNS and_CC children_NNS (_( 6_CD Go_NP Go_NP Go_NP Go_NP Go_NP Go_NP Go_NP Go_NP Go_NP Go_NP -16_NP Go_NP )_) ,_, and_CC ,_, in_IN adults_NNS ,_, several_JJ studies_NNS have_VBP found_VBN an_DT inverse_JJ association_NN between_IN physical_JJ activity_NN or_CC physical_JJ fitness_NN and_CC plasma_NN fibrinogen_NN level_NN (_( 17_CD Go_NP Go_NP Go_NP Go_NP Go_NP -22_NP Go_NP )_) ._SENT The_DT mechanism_NN of_IN these_DT associations_NNS is_VBZ not_RB clear_JJ ,_, but_CC there_EX is_VBZ some_DT evidence_NN that_IN exercise_NN may_MD have_VB a_DT direct_JJ effect_NN on_IN plasma_NN fibrinogen_NN level_NN (_( 19_CD Go_NP ,_, 23_NP Go_NP )_) ._SENT Fibrinogen_NN is_VBZ a_DT dimer_NN ,_, each_DT half_NN of_IN which_WDT is_VBZ assembled_VBN from_IN three_CD component_NN chains_NNS produced_VBN in_IN the_DT liver_NN (_( 2_CD {_( alpha_NN }_) +_SYM 2_CD {_( gamma_NN }_) +_SYM 2ß_JJ )_) ._SENT Because_IN synthesis_NN of_IN the_DT ß_NP chain_NN is_VBZ the_DT rate-limiting_JJ step_NN (_( 24_CD Go_NP )_) ,_, interest_NN in_IN genetic_JJ regulation_NN of_IN fibrinogen_NN levels_NNS has_VBZ focused_VBN on_IN polymorphisms_NNS in_IN the_DT ß-fibrinogen_NP promoter_NN region_NN ._SENT Several_JJ investigators_NNS have_VBP reported_VBN an_DT association_NN between_IN the_DT presence_NN of_IN the_DT common_JJ G[-455]-to-A_NP mutation_NN in_IN the_DT ß-fibrinogen_NP promoter_NN and_CC increased_VBN plasma_NN fibrinogen_NN levels_NNS in_IN adults_NNS (_( 25_CD Go_NP Go_NP Go_NP -28_NP Go_NP )_) ._SENT Two_CD studies_NNS in_IN adults_NNS have_VBP examined_VBN the_DT association_NN between_IN fitness_NN and_CC plasma_NN fibrinogen_NN taking_VBG into_IN account_NN the_DT variability_NN in_IN plasma_NN fibrinogen_NN level_NN attributable_JJ to_TO measured_VBN genetic_JJ characteristics_NNS (_( 19_CD Go_NP ,_, 22_NP Go_NP )_) ._SENT No_DT such_JJ studies_NNS in_IN children_NNS have_VBP been_VBN reported_VBN to_TO our_PP$ knowledge_NN ._SENT Several_JJ recent_JJ studies_NNS have_VBP reported_VBN a_DT positive_JJ association_NN between_IN measures_NNS of_IN obesity_NN ,_, specifically_RB body_NN mass_NN index_NN ,_, and_CC plasma_NN fibrinogen_NN in_IN children_NNS (_( 29_CD Go_NP Go_NP Go_NP -32_NP Go_NP )_) ._SENT Only_RB one_CD of_IN these_DT studies_NNS in_IN children_NNS included_VBD genotyping_NN of_IN the_DT ß-fibrinogen_NP promoter_NN and_CC adjusted_VBN for_IN this_DT covariate_NN in_IN the_DT analysis_NN (_( 33_CD Go_NP )_) ._SENT In_IN addition_NN ,_, higher_JJR fibrinogen_NN levels_NNS have_VBP been_VBN reported_VBN in_IN children_NNS whose_WP$ parents_NNS have_VBP a_DT positive_JJ history_NN of_IN cardiovascular_JJ disease_NN (_( 33_CD Go_NP Go_NP -35_NP Go_NP )_) ._SENT We_PP examined_VBD the_DT hypothesis_NN that_IN there_EX is_VBZ an_DT inverse_JJ association_NN between_IN physical_JJ fitness_NN and_CC plasma_NN fibrinogen_NN level_NN in_IN children_NNS ._SENT We_PP took_VBD into_IN account_NN measures_NNS of_IN obesity_NN ,_, family_NN history_NN of_IN early_JJ onset_NN coronary_JJ heart_NN disease_NN ,_, and_CC the_DT presence_NN of_IN the_DT G[-455]-to-A_NP mutation_NN in_IN the_DT ß-fibrinogen_NP promoter_NN gene_NN ._SENT MATERIALS_NNS AND_CC METHODS_NP TOP_NP ABSTRACT_NP INTRODUCTION_NP MATERIALS_NP AND_CC METHODS_NP RESULTS_NP DISCUSSION_NP REFERENCES_NP Subjects_VBZ The_DT Columbia_NP University_NP BioMarkers_NP Study_NP is_VBZ a_DT cross-sectional_JJ study_NN of_IN children_NNS and_CC their_PP$ parents_NNS conducted_VBN from_IN 1994_CD to_TO 1998_CD ._SENT Families_NNS were_VBD recruited_VBN through_IN high-risk_JJ cardiovascular_JJ clinics_NNS and_CC pediatric_JJ practices_NNS at_IN Columbia-Presbyterian_NP Medical_NP Center_NP ,_, lists_VBZ of_IN cardiac_JJ patients_NNS generated_VBN through_IN the_DT Presbyterian_NP Hospital_NP Clinical_NP Information_NP System_NP ,_, private_JJ cardiology_NN practices_NNS ,_, and_CC fliers_NNS posted_VBD within_IN the_DT medical_JJ center_NN ._SENT Families_NNS with_IN at_IN least_JJS one_CD healthy_JJ child_NN 4-25_CD years_NNS of_IN age_NN were_VBD eligible_JJ for_IN participation_NN ._SENT A_DT total_NN of_IN 612_CD children_NNS and_CC 444_CD parents_NNS from_IN 351_CD eligible_JJ families_NNS were_VBD recruited_VBN for_IN the_DT study_NN ._SENT This_DT analysis_NN included_VBD all_DT 193_CD children_NNS from_IN 185_CD families_NNS who_WP completed_VBD a_DT treadmill_NN fitness_NN test_NN and_CC had_VBD plasma_NN fibrinogen_NN level_NN measurements_NNS ._SENT Of_IN the_DT 419_CD children_NNS not_RB included_VBD in_IN this_DT analysis_NN ,_, 257_CD did_VBD not_RB perform_VB the_DT treadmill_NN test_NN because_IN ,_, for_IN logistic_JJ and_CC practical_JJ reasons_NNS ,_, the_DT design_NN of_IN the_DT study_NN called_VBN for_IN examination_NN of_IN only_RB one_CD child_NN per_IN family_NN (_( the_DT oldest_JJS one_CD )_) ._SENT An_DT additional_JJ 23_CD children_NNS did_VBD not_RB perform_VB the_DT treadmill_NN test_NN because_IN they_PP did_VBD not_RB have_VB proper_JJ shoes_NNS ,_, were_VBD late_JJ for_IN the_DT appointment_NN ,_, had_VBD asthma_NN or_CC history_NN of_IN heart_NN murmur_NN ,_, or_CC refused_VBD to_TO perform_VB the_DT test_NN ._SENT An_DT additional_JJ 133_CD children_NNS performed_VBD the_DT treadmill_NN test_NN but_CC completed_VBD only_RB one_CD stage_NN (_( n_NN =_SYM 62_CD )_) ,_, so_RB that_DT linear_JJ extrapolation_NN to_TO a_DT heart_NN rate_NN value_NN of_IN 170_CD beats_NNS per_IN minute_NN was_VBD not_RB possible_JJ ,_, or_CC completed_VBD multiple_JJ stages_NNS (_( n_NN =_SYM 71_CD )_) but_CC had_VBD data_NN points_NNS that_WDT did_VBD not_RB meet_VB criteria_NNS for_IN linear_JJ extrapolation_NN ._SENT An_DT additional_JJ threee_NN children_NNS who_WP had_VBD analyzable_JJ treadmill_NN tests_NNS did_VBD not_RB have_VB plasma_NN fibrinogen_NN analyses_NNS ,_, and_CC three_CD more_JJR children_NNS did_VBD not_RB have_VB the_DT resting_JJ heart_NN rate_NN measured_VBD ._SENT The_DT study_NN was_VBD approved_VBN by_IN the_DT Institutional_NP Review_NP Board_NP of_IN Columbia_NP Presbyterian_NP Medical_NP Center_NP ._SENT Measure_NN of_IN fitness_NN level_NN Fitness_NP level_NN was_VBD measured_VBN using_VBG a_DT treadmill_NN (_( Quinton_NP Instrument_NP Co._NP ,_, Bothell_NP ,_, Washington_NP )_) following_VBG the_DT PWC[170_NN ]_SYM protocol_NN (_( 16_CD Go_NP )_) ,_, which_WDT measures_VBZ physical_JJ work_NN capacity_NN (_( PWC_NP )_) at_IN a_DT heart_NN rate_NN of_IN 170_CD beats_NNS per_IN minute_NN ._SENT This_DT protocol_NN was_VBD selected_VBN because_IN it_PP gives_VBZ a_DT measure_NN of_IN fitness_NN that_WDT is_VBZ minimally_RB effort_NN dependent_NN (_( 36_CD Go_NP )_) and_CC is_VBZ therefore_RB useful_JJ in_IN children_NNS ,_, who_WP do_VBP not_RB give_VB a_DT reproducible_JJ maximal_JJ effort_NN when_WRB treadmill_NN tested_VBD ._SENT Children_NNS walked_VBD on_IN a_DT standard_JJ treadmill_NN at_IN a_DT speed_NN of_IN 4_CD km_NN per_IN hour_NN starting_VBG at_IN 0_CD percent_NN grade_NN for_IN 2_CD minutes_NNS ,_, after_IN which_WDT the_DT grade_NN was_VBD increased_VBN by_IN 5_CD percent_NN every_DT 2_CD minutes_NNS ._SENT Heart_NN rate_NN was_VBD monitored_VBN with_IN a_DT Polar_NP Vantage_NP XL_NP heart_NN rate_NN monitor_NN (_( Polar_NP Electro_NP ,_, Inc._NP ,_, Woodbury_NP ,_, New_NP York_NP )_) ._SENT The_DT test_NN was_VBD terminated_VBN when_WRB the_DT heart_NN rate_NN reached_VBD 170_CD beats_NNS per_IN minute_NN or_CC when_WRB the_DT child_NN could_MD no_RB longer_RBR continue_VB ,_, at_IN which_WDT point_NN the_DT grade_NN was_VBD returned_VBN to_TO 0_CD percent_NN and_CC the_DT child_NN continued_VBD to_TO walk_VB for_IN 2_CD more_JJR minutes_NNS ._SENT The_DT heart_NN rate_NN was_VBD plotted_VBN against_IN work_NN stage_NN and_CC extrapolated_VBN in_IN a_DT linear_JJ fashion_NN to_TO the_DT percent_NN grade_NN corresponding_JJ to_TO a_DT heart_NN rate_NN of_IN 170_CD beats_NNS per_IN minute_NN ._SENT This_DT work_NN level_NN was_VBD the_DT index_NN of_IN aerobic_JJ fitness_NN ._SENT Forty-nine_NN percent_NN of_IN the_DT children_NNS reached_VBD a_DT heart_NN rate_NN of_IN 170_CD beats_NNS per_IN minute_NN during_IN the_DT test_NN ._SENT Thus_RB ,_, extrapolation_NN was_VBD needed_VBN for_IN 51_CD percent_NN in_IN order_NN to_TO assign_VB a_DT fitness_NN score_NN ._SENT Resting_JJ heart_NN rate_NN was_VBD measured_VBN with_IN a_DT Dinamap_NP automated_JJ monitor_NN (_( Critikon_NP Company_NP ,_, L.L.C._NP ,_, Tampa_NP ,_, Florida_NP )_) before_IN the_DT exercise_NN test_NN ._SENT The_DT child_NN sat_VBD quietly_RB ,_, and_CC the_DT heart_NN rate_NN was_VBD recorded_VBN after_IN 3_CD minutes_NNS of_IN rest_NN ._SENT Measures_NNS of_IN family_NN history_NN ,_, obesity_NN ,_, and_CC other_JJ clinical_JJ characteristics_NNS Medical_NP histories_NNS were_VBD obtained_VBN through_IN individualized_VBN interviews_NNS conducted_VBN in_IN English_JJ or_CC Spanish_JJ using_VBG structured_JJ questionnaires_NNS ._SENT Information_NN on_IN ischemic_JJ heart_NN disease_NN in_IN family_NN members_NNS was_VBD verified_VBN where_WRB possible_JJ by_IN review_NN of_IN medical_JJ records_NNS ._SENT Family_NN history_NN of_IN early_JJ onset_NN ischemic_JJ heart_NN disease_NN was_VBD classified_VBN as_IN positive_JJ if_IN one_CD or_CC both_DT parents_NNS had_VBD early_JJ onset_NN of_IN clinical_JJ ischemic_JJ heart_NN disease_NN (_( <=_NN 55_CD years_NNS of_IN age_NN for_IN men_NNS and_CC <=_JJ 65_CD years_NNS of_IN age_NN for_IN women_NNS )_) as_RB indicated_VBD by_IN a_DT history_NN of_IN myocardial_JJ infarction_NN ,_, coronary_JJ artery_NN bypass_NN surgery_NN ,_, coronary_JJ angioplasty_JJ ,_, or_CC sudden_JJ death_NN ,_, either_CC documented_VBN in_IN medical_JJ records_NNS or_CC by_IN self_NN report_NN ,_, or_CC coronary_JJ arteriographic_JJ documentation_NN of_IN 50_CD percent_NN or_CC greater_JJR narrowing_NN of_IN the_DT luminal_JJ diameter_NN of_IN one_CD or_CC more_JJR major_JJ epicardial_JJ coronary_JJ arteries_NNS ._SENT Family_NN history_NN was_VBD classified_VBN as_IN indeterminate_JJ if_IN family_NN members_NNS were_VBD unsure_JJ of_IN their_PP$ medical_JJ history_NN or_CC if_IN there_EX was_VBD a_DT history_NN of_IN early_JJ onset_NN ischemic_JJ heart_NN disease_NN in_IN one_CD or_CC more_JJR of_IN the_DT grandparents_NNS ._SENT Family_NN history_NN was_VBD categorized_VBN as_IN negative_JJ if_IN the_DT self-reported_JJ medical_JJ history_NN was_VBD negative_JJ for_IN early_JJ onset_NN ischemic_JJ heart_NN disease_NN in_IN both_DT parents_NNS and_CC all_DT four_CD grandparents_NNS ._SENT Race_NN and_CC ethnicity_NN were_VBD categorized_VBN on_IN the_DT basis_NN of_IN the_DT mother_NN 's_POS self-report_NN ,_, following_VBG definitions_NNS used_VBN in_IN the_DT US_NP Census_NP of_IN 1990_CD (_( 37_CD Go_NP )_) ,_, as_IN Hispanic_NP ,_, Black_NP but_CC not_RB of_IN Hispanic_JJ heritage_NN ,_, White_NP but_CC not_RB of_IN Hispanic_JJ heritage_NN ,_, or_CC Asian_NP or_CC Pacific_NP Islander_NP ._SENT The_DT race/ethnicity_NN of_IN children_NNS was_VBD based_VBN on_IN that_DT of_IN the_DT mother_NN ._SENT Because_IN some_DT families_NNS were_VBD recruited_VBN to_TO the_DT study_NN from_IN the_DT population_NN at_IN large_JJ ,_, while_IN others_NNS were_VBD recruited_VBN from_IN settings_NNS where_WRB either_RB a_DT parent_NN or_CC the_DT child_NN received_VBD medical_JJ treatment_NN for_IN hyperlipidemia_NN ,_, early_JJ onset_NN of_IN ischemic_JJ heart_NN disease_NN ,_, or_CC both_DT ,_, we_PP additionally_RB classified_VBD families_NNS as_IN having_VBG been_VBN recruited_VBN from_IN the_DT population_NN at_IN large_JJ or_CC a_DT high_JJ risk_NN setting_NN ._SENT The_DT high_JJ risk_NN settings_NNS were_VBD the_DT Columbia_NP University_NP 's_POS Children_NP 's_POS Cardiovascular_NP Health_NP Center_NP ,_, where_WRB children_NNS were_VBD referred_VBN for_IN diganosis_NN and_CC management_NN of_IN lipid_NN disorders_NNS ,_, the_DT cardiac_JJ catheterization_NN laboratory_NN ,_, lists_NNS derived_VBN from_IN private_JJ cardiology_NN practices_NNS of_IN patients_NNS with_IN early_JJ onset_NN ischemic_JJ heart_NN disease_NN ,_, and_CC similar_JJ patients_NNS identified_VBN from_IN hospital_NN computerized_JJ information_NN systems_NNS ._SENT Subjects_NNS recruited_VBN from_IN general_JJ pediatric_JJ practices_NNS or_CC through_IN fliers_NNS were_VBD classified_VBN as_IN recruited_VBN from_IN the_DT population_NN at_IN large_JJ (_( low_JJ risk_NN settings_NNS )_) ._SENT Height_NN was_VBD measured_VBN to_TO the_DT nearest_JJS centimeter_NN using_VBG a_DT rigid_JJ stadiometer_NN ._SENT Weight_NN was_VBD measured_VBN to_TO the_DT nearest_JJS 0.1_CD kg_NN using_VBG a_DT calibrated_VBN balance_NN scale_NN ._SENT Body_NN mass_NN index_NN was_VBD calculated_VBN as_IN the_DT weight_NN in_IN kilograms_NNS divided_VBN by_IN the_DT height_NN in_IN meters_NNS squared_VBD ._SENT Skinfolds_NNS were_VBD measured_VBN with_IN Lafayette_NP calipers_NNS (_( Lafayette_NP Instrument_NP Co._NP ,_, Inc._NP ,_, Lafayette_NP ,_, Indiana_NP )_) on_IN the_DT right_JJ side_NN of_IN the_DT body_NN at_IN five_CD sites_NNS :_: triceps_NNS ,_, subscapular_JJ ,_, suprailiac_JJ ,_, abdominal_JJ ,_, and_CC thigh_NN (_( 38_CD Go_NP )_) ._SENT Each_DT site_NN was_VBD measured_VBN twice_RB and_CC the_DT mean_JJ value_NN was_VBD recorded_VBN ._SENT If_IN the_DT two_CD values_NNS differed_VBN by_IN more_JJR than_IN 2_CD mm_NN ,_, a_DT third_JJ measurement_NN was_VBD taken_VBN ,_, and_CC the_DT mean_NN of_IN the_DT two_CD closest_JJS measures_NNS was_VBD recorded_VBN ._SENT The_DT sum_NN of_IN skinfolds_NNS was_VBD calculated_VBN as_IN the_DT sum_NN of_IN the_DT values_NNS for_IN the_DT five_CD sites_NNS ._SENT Biochemical_JJ and_CC genetic_JJ analyses_NNS Subjects_NNS were_VBD instructed_VBN to_TO fast_VB after_IN dinner_NN the_DT night_NN before_IN the_DT interview_NN ,_, except_IN for_IN water_NN ,_, and_CC blood_NN samples_NNS were_VBD obtained_VBN at_IN the_DT start_NN of_IN the_DT interview_NN prior_RB to_TO the_DT fitness_NN assessment_NN ._SENT The_DT fibrinogen_NN level_NN was_VBD determined_VBN from_IN citrated_JJ plasma_NN ,_, using_VBG a_DT semiautomated_JJ instrument_NN (_( Diagnostica_NP Stago_NP ;_: American_NP Bioproducts_NP ,_, Persippany_NP ,_, New_NP York_NP )_) based_VBN on_IN the_DT clot_NN rate_NN method_NN of_IN Geftkin_NP et_FW al._FW (_( 39_CD Go_NP )_) ._SENT The_DT presence_NN of_IN the_DT G-to-A_NP substitution_NN at_IN position_NN -455_CD in_IN the_DT ß-fibrinogen_NP promoter_NN was_VBD detected_VBN by_IN polymerase_NN chain_NN reaction_NN amplification_NN of_IN genomic_JJ DNA_NN and_CC digestion_NN with_IN the_DT restriction_NN enzyme_NN HaeIII_NP (_( 40_NP Go_NP )_) ._SENT The_DT frequency_NN (_( proportion_NN )_) of_IN the_DT A_NP allele_NN was_VBD calculated_VBN as_IN the_DT number_NN of_IN A_DT alleles_NNS divided_VBN by_IN the_DT total_JJ number_NN of_IN alleles_NNS (_( 2N_NP ,_, where_WRB N_NP =_SYM the_DT number_NN of_IN subjects_NNS )_) ._SENT Statistical_JJ analysis_NN Frequencies_NNS ,_, means_NNS ,_, and_CC standard_JJ deviations_NNS were_VBD calculated_VBN for_IN each_DT variable_NN ._SENT Bivariate_NP analyses_NNS included_VBD t_NN tests_NNS for_IN differences_NNS in_IN means_NNS between_IN groups_NNS and_CC Pearson_NP 's_POS correlation_NN coefficients_NNS for_IN continuous_JJ variables_NNS ._SENT Measures_NNS of_IN fitness_NN level_NN (_( PWC[170_NP ]_SYM work_NN stage_NN and_CC resting_JJ heart_NN rate_NN )_) and_CC measures_NNS of_IN obesity_NN (_( body_NN mass_NN index_NN ,_, sum_NN of_IN skinfolds_NNS )_) were_VBD divided_VBN into_IN tertiles_NNS ._SENT Mean_JJ fibrinogen_NN levels_NNS were_VBD reported_VBN for_IN each_DT tertile_NN ,_, and_CC linear_JJ trends_NNS were_VBD tested_VBN using_VBG linear_JJ regression_NN analyses_NNS using_VBG coded_VBN values_NNS of_IN 1_CD ,_, 2_CD ,_, and_CC 3_CD for_IN lowest_JJS ,_, mid_JJ ,_, and_CC highest_JJS tertile_NN ._SENT The_DT associations_NNS of_IN PWC[170_NP ]_SYM work_NN stage_NN and_CC resting_JJ heart_NN rate_NN with_IN plasma_NN fibrinogen_NN were_VBD assessed_VBN in_IN separate_JJ multiple_JJ linear_JJ regression_NN models_NNS ,_, adjusted_VBN for_IN age_NN ,_, sex_NN ,_, race/ethnicity_NN ,_, family_NN history_NN of_IN early_JJ onset_NN ischemic_JJ heart_NN disease_NN ,_, presence_NN of_IN the_DT A_NP allele_NN in_IN the_DT -455_CD position_NN of_IN the_DT ß-fibrinogen_NP promoter_NN gene_NN ,_, and_CC a_DT measure_NN of_IN obesity_NN (_( body_NN mass_NN index_NN ,_, sum_NN of_IN skinfolds_NNS ,_, or_CC subscapular/triceps_NNS ratio_NN )_) ._SENT The_DT subscapular/triceps_NNS ratio_NN was_VBD considered_VBN an_DT index_NN of_IN central_JJ obesity_NN ._SENT In_IN six_CD children_NNS information_NN on_IN race/ethnicity_NN was_VBD missing_VBG ,_, and_CC in_IN 16_CD children_NNS genotype_NN data_NNS were_VBD not_RB available_JJ ;_: these_DT children_NNS were_VBD excluded_VBN from_IN multivariate_JJ analyses_NNS ._SENT Because_IN of_IN the_DT small_JJ number_NN (_( n_NN =_SYM 13_CD )_) of_IN children_NNS with_IN race/ethnicity_NN other_JJ than_IN Hispanic_NP or_CC non-Hispanic_NP White_NP ,_, these_DT children_NNS were_VBD also_RB excluded_VBN from_IN multiple_JJ regression_NN models_NNS ;_: thus_RB ,_, race/ethnicity_NN comparisons_NNS refer_VBP to_TO Hispanic_NP versus_CC non-Hispanic_NP White_NP differences_NNS ._SENT One_CD additional_JJ child_NN did_VBD not_RB have_VB measurements_NNS for_IN calculation_NN of_IN body_NN mass_NN index_NN ,_, and_CC this_DT child_NN was_VBD excluded_VBN when_WRB analyses_NNS involved_VBD this_DT covariate_NN ._SENT Five_CD children_NNS in_IN the_DT sample_NN had_VBD siblings_NNS who_WP were_VBD also_RB included_VBN in_IN the_DT sample_NN ;_: only_RB the_DT oldest_JJS child_NN in_IN these_DT five_CD sibships_NNS was_VBD included_VBN in_IN the_DT multivariate_JJ analysis_NN ._SENT Statistical_JJ analyses_NNS were_VBD performed_VBN with_IN SPSS-PC_NP software_NN (_( SPSS_NP for_IN Windows_NP ,_, version_NN 7.5_CD ;_: SPSS_NP ,_, Inc._NP ,_, Chicago_NP ,_, Illinois_NP )_) ._SENT RESULTS_VBZ TOP_NP ABSTRACT_NP INTRODUCTION_NP MATERIALS_NP AND_CC METHODS_NP RESULTS_NP DISCUSSION_NP REFERENCES_NP The_DT mean_JJ age_NN of_IN the_DT 193_CD children_NNS included_VBN in_IN the_DT analysis_NN was_VBD 11.1_CD years_NNS (_( standard_JJ deviation_NN (_( SD_NP )_) ,_, 3.8_CD ;_: range_NN ,_, 4-25_CD years_NNS )_) ;_: 46_CD percent_NN were_VBD male_JJ and_CC 68_CD percent_NN were_VBD Hispanic_JJ (_( table_NN 1_CD )_) ._SENT Boys_NNS had_VBD somewhat_RB lower_JJR plasma_NN fibrinogen_NN levels_NNS and_CC higher_JJR levels_NNS of_IN fitness_NN as_IN measured_VBN by_IN both_DT PWC[170_NN ]_SYM work_NN stage_NN and_CC resting_JJ heart_NN rate_NN ,_, compared_VBN with_IN girls_NNS ._SENT The_DT mean_JJ body_NN mass_NN index_NN and_CC sum_NN of_IN skinfolds_NNS were_VBD similar_JJ in_IN boys_NNS and_CC girls_NNS ._SENT The_DT overall_JJ frequency_NN of_IN the_DT G-to-A_NP mutation_NN was_VBD 0.17_CD ._SENT As_IN expected_VBN ,_, the_DT 133_CD children_NNS who_WP did_VBD not_RB complete_VB the_DT treadmill_NN fitness_NN assessment_NN were_VBD younger_JJR than_IN the_DT 193_CD who_WP did_VBD (_( mean_JJ age_NN ,_, 8.5_NP (_( SD_NP ,_, 3.7_CD )_) years_NNS ;_: p_NN <_SYM 0.001_CD )_) and_CC smaller_JJR (_( mean_JJ body_NN mass_NN index_NN ,_, 19.3_NP (_( SD_NP ,_, 5.1_CD )_) kg/m2_NN ;_: p_NN <_SYM 0.001_CD )_) ._SENT The_DT mean_JJ plasma_NN fibrinogen_NN levels_NNS were_VBD not_RB significantly_RB different_JJ between_IN the_DT included_VBN children_NNS (_( 278.2_CD (_( SD_NP ,_, 48.6_CD )_) mg/dl_NN )_) and_CC those_DT who_WP did_VBD not_RB complete_VB the_DT fitness_NN assessment_NN (_( 267.2_CD (_( SD_NP ,_, 55.1_CD )_) mg/dl_NP )_) (_( p_NN =_SYM 0.07_CD )_) ._SENT View_VB this_DT table_NN :_: TABLE_NN 1_CD ._SENT Selected_JJ characteristics_NNS of_IN 193_CD children_NNS in_IN the_DT Columbia_NP University_NP BioMarkers_NP Study_NP ,_, New_NP York_NP ,_, 1994-1998_CD As_IN shown_VBN in_IN table_NN 2_CD ,_, among_IN the_DT 193_CD children_NNS included_VBN in_IN the_DT analysis_NN ,_, the_DT plasma_NN fibrinogen_NN level_NN was_VBD positively_RB and_CC significantly_RB correlated_VBN with_IN body_NN mass_NN index_NN ,_, sum_NN of_IN skinfolds_NNS ,_, and_CC resting_JJ heart_NN rate_NN (_( r_LS =_SYM 0.17_CD ,_, 0.27_CD ,_, and_CC 0.18_CD ,_, respectively_RB )_) and_CC inversely_RB correlated_VBN with_IN work_NN stage_NN by_IN PWC[170_NP ]_SYM (_( r_LS =_SYM -0.24_CD )_) ._SENT As_IN expected_VBN ,_, the_DT resting_JJ heart_NN rate_NN and_CC work_NN stage_NN by_IN PWC[170_NP ]_SYM were_VBD strongly_RB and_CC inversely_RB correlated_VBD (_( r_LS =_SYM -0.44_CD )_) ._SENT Work_NN stage_NN by_IN PWC[170_NP ]_SYM was_VBD positively_RB correlated_VBN with_IN age_NN and_CC inversely_RB correlated_VBN with_IN the_DT sum_NN of_IN skinfolds_NNS (_( r_LS =_SYM 0.29_CD and_CC -0.27_CD ,_, respectively_RB )_) ._SENT View_VB this_DT table_NN :_: TABLE_NN 2_CD ._SENT Pearson_NP 's_POS correlation_NN coefficients_NNS for_IN fibrinogen_NN level_NN ,_, PWC[170_NP ]_SYM {_( dagger_NN }_) work_NN stage_NN ,_, resting_VBG heart_NN rate_NN ,_, age_NN ,_, body_NN mass_NN index_NN ,_, and_CC sum_NN of_IN skinfolds_NNS ,_, Columbia_NP University_NP BioMarkers_NP Study_NP ,_, New_NP York_NP ,_, 1994-1998_CD (_( n_NN =_SYM 193_CD )_) The_DT plasma_NN fibrinogen_NN level_NN showed_VBD an_DT inverse_JJ relation_NN over_IN tertiles_NNS of_IN PWC[170_NP ]_SYM work_NN stage_NN (_( p_NN for_IN linear_JJ trend_NN <_SYM 0.001_CD )_) and_CC a_DT progressive_JJ positive_JJ relation_NN with_IN resting_JJ heart_NN rate_NN (_( p_NN for_IN linear_JJ trend_NN =_SYM 0.002_CD )_) (_( table_NN 3_CD )_) ._SENT We_PP also_RB examined_VBD the_DT relation_NN of_IN the_DT plasma_NN fibrinogen_NN level_NN to_TO fitness_NN within_IN strata_NNS of_IN the_DT body_NN mass_NN index_NN and_CC sum_NN of_IN skinfolds_NNS ._SENT The_DT mean_JJ plasma_NN fibrinogen_NN level_NN decreased_VBD progressively_RB with_IN higher_JJR tertiles_NNS of_IN PWC[170_NP ]_SYM work_NN stage_NN within_IN each_DT stratum_NN of_IN body_NN mass_NN index_NN ,_, although_IN the_DT trend_NN test_NN for_IN fibrinogen_NN level_NN in_IN relation_NN to_TO PWC[170_NP ]_SYM was_VBD statistically_RB significant_JJ only_RB in_IN the_DT highest_JJS stratum_NN of_IN body_NN mass_NN index_NN ._SENT The_DT findings_NNS were_VBD similar_JJ in_IN analyses_NNS stratified_VBN by_IN tertile_NN of_IN the_DT sum_NN of_IN skinfolds_NNS ._SENT The_DT results_NNS of_IN similar_JJ analyses_NNS stratified_VBN by_IN body_NN mass_NN index_NN and_CC the_DT sum_NN of_IN skinfolds_NNS relating_VBG fibrinogen_NN level_NN to_TO resting_JJ heart_NN rate_NN were_VBD also_RB consistent_JJ ._SENT View_VB this_DT table_NN :_: TABLE_NN 3_CD ._SENT Mean_JJ fibrinogen_NN level_NN according_VBG to_TO tertiles_NNS of_IN PWC[170]*_NP and_CC resting_JJ heart_NN rate_NN ,_, Columbia_NP University_NP BioMarkers_NP Study_NP ,_, New_NP York_NP ,_, 1994-1998_CD (_( n_NN =_SYM 193_CD )_) Plasma_NP fibrinogen_NN did_VBD not_RB vary_VB significantly_RB by_IN genotype_NN in_IN the_DT 455_CD position_NN of_IN the_DT ß-fibrinogen_NP promoter_NN gene_NN ._SENT The_DT mean_JJ plasma_NN fibrinogen_NN level_NN was_VBD 281.6_CD (_( SD_NP ,_, 48.3_CD )_) mg/dl_NN for_IN those_DT with_IN the_DT GG_NP genotype_NN (_( n_NN =_SYM 121_CD )_) ,_, 271.0_NP (_( SD_NP ,_, 48.6_CD )_) mg/dl_NN for_IN those_DT who_WP were_VBD GA_NP (_( n_NN =_SYM 52_CD )_) at_IN this_DT locus_NN ,_, and_CC 302.0_CD (_( SD_NP ,_, 62.4_CD )_) mg/dl_NN for_IN those_DT who_WP were_VBD AA_NP (_( n_NN =_SYM 4_CD )_) ._SENT We_PP examined_VBD the_DT relation_NN between_IN fitness_NN and_CC plasma_NN fibrinogen_NN level_NN in_IN an_DT analysis_NN stratified_VBN by_IN genotype_NN at_IN this_DT locus_NN ._SENT There_EX was_VBD an_DT inverse_JJ progressive_JJ relation_NN between_IN plasma_NN fibrinogen_NN and_CC tertile_NN of_IN PWC[170_NP ]_SYM work_NN stage_NN for_IN GG_NP carriers_NNS (_( mean_JJ plasma_NN fibrinogen_NN in_IN lowest_JJS to_TO highest_JJS tertile_NN of_IN PWC[170_NP ]_SYM :_: 296.2_CD mg/dl_NN ,_, 282.9_CD mg/dl_NN ,_, and_CC 261.6_CD mg/dl_NN ;_: p_NN for_IN linear_JJ trend_NN =_SYM 0.001_CD )_) ;_: the_DT same_JJ trend_NN was_VBD observed_VBN in_IN the_DT smaller_JJR number_NN of_IN children_NNS (_( n_NN =_SYM 56_CD )_) with_IN the_DT G-to-A_NP mutation_NN (_( GA_NP or_CC AA_NP carriers_NNS )_) ,_, although_IN the_DT trend_NN was_VBD not_RB statistically_RB significant_JJ (_( mean_JJ fibrinogen_NN in_IN lowest_JJS to_TO highest_JJS tertile_NN of_IN PWC[170_NP ]_SYM :_: 284.7_CD mg/dl_NN ,_, 275.7_CD mg/dl_NN ,_, and_CC 265.3_CD mg/dl_NN ;_: p_NN for_IN linear_JJ trend_NN =_SYM 0.31_CD )_) ._SENT Similarly_RB ,_, the_DT association_NN between_IN resting_JJ heart_NN rate_NN and_CC plasma_NN fibrinogen_NN level_NN was_VBD also_RB present_JJ in_IN analyses_NNS stratified_VBN by_IN the_DT presence_NN of_IN the_DT G-to-A_NP mutation_NN ._SENT Again_RB ,_, the_DT linear_JJ trend_NN reached_VBD statistical_JJ significance_NN only_RB among_IN the_DT GG_NP subjects_NNS ._SENT Forty-six_NP children_NNS (_( 24_CD percent_NN )_) had_VBD a_DT positive_JJ family_NN history_NN of_IN early_JJ onset_NN ischemic_JJ heart_NN disease_NN ._SENT In_IN this_DT group_NN ,_, the_DT mean_JJ plasma_NN fibrinogen_NN level_NN was_VBD similar_JJ to_TO levels_NNS in_IN the_DT 106_CD children_NNS with_IN negative_JJ family_NN history_NN (_( mean_VB ,_, 273.7_NP (_( SD_NP ,_, 48.3_CD )_) mg/dl_NN and_CC 279.7_CD (_( SD_NP ,_, 48.8_CD )_) mg/dl_NN ,_, respectively_RB )_) ._SENT Multiple_JJ linear_JJ regression_NN analysis_NN showed_VBD that_IN ,_, after_IN adjustment_NN for_IN age_NN ,_, sex_NN ,_, race/ethnicity_NN ,_, family_NN history_NN of_IN early_JJ onset_NN ischemic_JJ heart_NN disease_NN ,_, presence_NN of_IN the_DT A_NP allele_NN in_IN the_DT -455_CD position_NN of_IN the_DT ß-fibrinogen_NP promoter_NN gene_NN ,_, and_CC body_NN mass_NN index_NN ,_, a_DT higher_JJR level_NN of_IN fitness_NN as_IN indexed_VBN by_IN PWC[170_NP ]_SYM work_NN stage_NN was_VBD associated_VBN with_IN lower_JJR plasma_NN fibrinogen_NN levels_NNS (_( ß_NP =_SYM -1.3_CD ,_, 95_CD percent_NN confidence_NN interval_NN (_( CI_NP )_) :_: -2.3_CD ,_, -0.34_CD )_) (_( table_NN 4_CD )_) ._SENT When_WRB the_DT model_NN included_VBD the_DT sum_NN of_IN skinfolds_NNS in_IN place_NN of_IN the_DT body_NN mass_NN index_NN ,_, in_IN addition_NN to_TO the_DT other_JJ covariates_NNS mentioned_VBN above_IN ,_, PWC[170_NP ]_SYM work_NN stage_NN remained_VBD inversely_RB associated_VBN with_IN fibrinogen_NN levels_NNS (_( ß_NP =_SYM -1.1_CD ,_, 95_CD percent_NN CI_NP :_: -2.1_CD ,_, -0.17_CD )_) ._SENT Similar_JJ results_NNS were_VBD observed_VBN when_WRB adjusting_VBG for_IN the_DT ratio_NN of_IN subscapular_NN to_TO triceps_NN skinfold_NNS as_IN an_DT index_NN of_IN central_JJ obesity_NN instead_RB of_IN body_NN mass_NN index_NN ._SENT We_PP fitted_VBD similar_JJ models_NNS with_IN resting_JJ heart_NN rate_NN ,_, rather_RB than_IN PWC[170_NP ]_SYM work_NN stage_NN ,_, as_IN the_DT index_NN of_IN aerobic_JJ fitness_NN ._SENT In_IN the_DT model_NN using_VBG body_NN mass_NN index_NN as_IN the_DT measure_NN of_IN obesity_NN and_CC adjusting_VBG for_IN age_NN ,_, sex_NN ,_, race/ethnicity_NN ,_, family_NN history_NN of_IN early_JJ onset_NN ischemic_JJ heart_NN disease_NN ,_, and_CC presence_NN of_IN the_DT A_NP allele_NN in_IN the_DT -455_CD position_NN of_IN the_DT ß-fibrinogen_NP promoter_NN gene_NN ,_, the_DT plasma_NN fibrinogen_NN level_NN increased_VBD significantly_RB with_IN resting_JJ heart_NN rate_NN (_( ß_NP =_SYM 0.83_CD ,_, 95_CD percent_NN CI_NP :_: 0.17_CD ,_, 1.5_CD )_) ._SENT In_IN a_DT similar_JJ model_NN but_CC with_IN the_DT sum_NN of_IN skinfolds_NNS as_IN the_DT index_NN of_IN obesity_NN ,_, the_DT association_NN was_VBD also_RB found_VBN (_( ß_NP =_SYM 0.77_CD ,_, 95_CD percent_NN CI_NP :_: 0.12_CD ,_, 1.4_CD )_) ._SENT Several_JJ confirmatory_JJ analyses_NNS were_VBD also_RB performed_VBN ._SENT We_PP fitted_VBD the_DT same_JJ multivariate_JJ model_NN shown_VBN in_IN table_NN 4_CD for_IN children_NNS under_IN 13_CD years_NNS of_IN age_NN (_( n_NN =_SYM 123_CD )_) ._SENT The_DT results_NNS of_IN this_DT subgroup_NN analysis_NN were_VBD consistent_JJ with_IN the_DT findings_NNS for_IN the_DT sample_NN as_IN a_DT whole_JJ (_( coefficient_NN for_IN PWC[170_NP ]_SYM (_( ß_NP )_) =_SYM -1.4_CD ,_, 95_CD percent_NN CI_NP :_: -2.7_CD ,_, -0.2_CD ;_: p_NN =_SYM 0.02_CD )_) ._SENT Separate_JJ multiple_JJ regression_NN models_NNS for_IN boys_NNS and_CC girls_NNS showed_VBD similar_JJ results_NNS ._SENT Children_NNS recruited_VBN from_IN high_JJ risk_NN settings_NNS (_( n_NN =_SYM 84_CD )_) were_VBD older_JJR than_IN children_NNS from_IN low_JJ risk_NN settings_NNS (_( n_NN =_SYM 109_CD )_) (_( mean_JJ age_NN ,_, 12.1_CD years_NNS vs._IN 10.4_CD years_NNS ;_: p_NN =_SYM 0.003_CD )_) and_CC had_VBD higher_JJR mean_JJ plasma_NN fibrinogen_NN levels_NNS (_( 285.9_CD mg/dl_NN vs._IN 272.2_CD mg/dl_NN ;_: p_NN =_SYM 0.049_CD )_) ._SENT The_DT mean_JJ body_NN mass_NN index_NN ,_, sum_NN of_IN skinfolds_NNS ,_, PWC[170_NP ]_SYM work_NN stage_NN ,_, and_CC resting_JJ heart_NN rate_NN were_VBD similar_JJ in_IN both_DT groups_NNS ._SENT Separate_JJ multiple_JJ regression_NN models_NNS for_IN children_NNS recruited_VBN from_IN high_JJ and_CC low_JJ risk_NN settings_NNS showed_VBD findings_NNS not_RB materially_RB different_JJ from_IN those_DT reported_VBN for_IN the_DT whole_JJ sample_NN ._SENT The_DT associations_NNS between_IN fitness_NN measures_NNS and_CC plasma_NN fibrinogen_NN level_NN were_VBD statistically_RB significant_JJ for_IN children_NNS recruited_VBN from_IN low_JJ risk_NN settings_NNS (_( ß_NP =_SYM -1.6_CD ,_, 95_CD percent_NN CI_NP :_: -2.9_CD ,_, -0.29_CD )_) but_CC not_RB in_IN the_DT smaller_JJR number_NN of_IN children_NNS in_IN the_DT high_JJ risk_NN group_NN (_( ß_NP =_SYM -0.5_CD ,_, 95_CD percent_NN CI_NP :_: -1.9_CD ,_, 0.83_CD )_) ._SENT We_PP also_RB fitted_VBD a_DT multiple_JJ regression_NN model_NN in_IN which_WDT we_PP adjusted_VBN for_IN recruitment_NN setting_VBG in_IN addition_NN to_TO age_NN ,_, sex_NN ,_, race/ethnicity_NN ,_, family_NN history_NN of_IN early_JJ onset_NN ischemic_JJ heart_NN disease_NN ,_, presence_NN of_IN the_DT A_NP allele_NN in_IN the_DT 455_CD position_NN of_IN the_DT ß-fibrinogen_NP promoter_NN gene_NN ,_, and_CC body_NN mass_NN index_NN ._SENT In_IN this_DT model_NN ,_, the_DT inverse_JJ association_NN between_IN fitness_NN level_NN and_CC plasma_NN fibrinogen_NN was_VBD similar_JJ in_IN magnitude_NN to_TO what_WP we_PP observed_VBD without_IN adjustment_NN for_IN site_NN of_IN recruitment_NN (_( ß_NP =_SYM -1.2_CD ,_, 95_CD percent_NN CI_NP :_: -2.1_CD ,_, -0.24_CD )_) ._SENT View_VB this_DT table_NN :_: TABLE_NN 4_CD ._SENT Multiple_JJ linear_JJ regression_NN for_IN mean_JJ fibrinogen_NN level_NN in_IN relation_NN to_TO age_NN ,_, sex_NN ,_, race/ethnicity_NN ,_, family_NN history_NN of_IN early_JJ onset_NN coronary_JJ heart_NN disease_NN ,_, presence_NN of_IN the_DT A_NP allele_NN in_IN the_DT -455_CD position_NN of_IN the_DT ß-fibrinogen_NP promoter_NN gene_NN ,_, body_NN mass_NN index_NN ,_, and_CC PWC[170],*_NP Columbia_NP University_NP BioMarkers_NP Study_NP ,_, New_NP York_NP ,_, 1994-1998_CD (_( n_NN =_SYM 163_CD )_) {_( dagger_NN }_) DISCUSSION_NP TOP_NP ABSTRACT_NP INTRODUCTION_NP MATERIALS_NP AND_CC METHODS_NP RESULTS_NP DISCUSSION_NP REFERENCES_NP In_IN this_DT study_NN of_IN 193_CD children_NNS ,_, the_DT plasma_NN fibrinogen_NN level_NN was_VBD inversely_RB associated_VBN with_IN physical_JJ fitness_NN as_IN measured_VBN by_IN the_DT PWC[170_NN ]_SYM treadmill_NN protocol_NN and_CC resting_JJ heart_NN rate_NN ._SENT These_DT associations_NNS remained_VBD significant_JJ after_IN adjustment_NN for_IN measures_NNS of_IN obesity_NN ,_, namely_RB ,_, body_NN mass_NN index_NN and_CC sum_NN of_IN skinfolds_NNS ,_, presence_NN of_IN the_DT G-to-A_NP mutation_NN at_IN position_NN -455_CD in_IN the_DT ß-fibrinogen_NP promoter_NN gene_NN ,_, and_CC other_JJ measured_JJ covariates_NNS ._SENT In_IN analyses_NNS stratified_VBN by_IN tertiles_NNS of_IN body_NN mass_NN index_NN ,_, the_DT plasma_NN fibrinogen_NN level_NN decreased_VBN with_IN increasing_VBG levels_NNS of_IN fitness_NN within_IN each_DT stratum_NN ,_, although_IN these_DT trends_NNS were_VBD statistically_RB significant_JJ only_RB in_IN the_DT highest_JJS stratum_NN of_IN body_NN mass_NN index_NN ._SENT Similar_JJ results_NNS were_VBD found_VBN in_IN analyses_NNS using_VBG the_DT sum_NN of_IN skinfolds_NNS rather_RB than_IN body_NN mass_NN index_NN as_IN the_DT measure_NN of_IN obesity_NN ._SENT We_PP did_VBD not_RB find_VB differences_NNS in_IN the_DT children_NNS in_IN our_PP$ study_NN in_IN mean_JJ plasma_NN fibrinogen_NN levels_NNS by_IN genotype_NN ,_, as_RB has_VBZ been_VBN reported_VBN by_IN others_NNS in_IN adult_JJ populations_NNS (_( 26_CD Go_NP ,_, 27_NP Go_NP )_) ._SENT The_DT inverse_JJ association_NN of_IN fibrinogen_NN level_NN with_IN physical_JJ fitness_NN was_VBD observed_VBN in_IN children_NNS with_IN and_CC without_IN the_DT presence_NN of_IN the_DT G-to-A_NP mutation_NN ,_, although_IN the_DT trend_NN was_VBD statistically_RB significant_JJ only_RB for_IN GG_NP carriers_NNS ,_, where_WRB the_DT number_NN of_IN subjects_NNS was_VBD larger_JJR ._SENT To_TO our_PP$ knowledge_NN ,_, only_RB one_CD other_JJ study_NN has_VBZ been_VBN reported_VBN evaluating_VBG the_DT association_NN between_IN physical_JJ exercise_NN or_CC fitness_NN and_CC fibrinogen_NN levels_NNS in_IN children_NNS ._SENT That_DT study_NN ,_, by_IN Zahavi_NP et_FW al._FW (_( 32_CD Go_NP )_) ,_, was_VBD conducted_VBN in_IN Israel_NP and_CC compared_VBN fibrinogen_NN levels_NNS in_IN a_DT sample_NN of_IN 860_CD Jewish_JJ and_CC 315_CD Israeli_JJ Moslem_JJ schoolchildren_NNS in_IN relation_NN to_TO cardiovascular_JJ disease_NN risk_NN factors_NNS ._SENT That_DT study_NN reported_VBD a_DT positive_JJ correlation_NN between_IN hours_NNS of_IN sport_NN activity_NN and_CC plasma_NN fibrinogen_NN among_IN Israeli_JJ Moslem_JJ children_NNS ,_, rather_RB than_IN the_DT expected_VBN inverse_NN correlation_NN ._SENT This_DT study_NN did_VBD not_RB measure_VB fitness_NN directly_RB or_CC adjust_VB for_IN measures_NNS of_IN obesity_NN ._SENT Several_JJ other_JJ studies_NNS have_VBP reported_VBN positive_JJ associations_NNS between_IN measures_NNS of_IN obesity_NN and_CC plasma_NN fibrinogen_NN in_IN children_NNS ._SENT Bao_NP et_FW al._FW (_( 31_CD Go_NP )_) reported_VBD data_NNS from_IN the_DT Bogalusa_NP Heart_NP Study_NP showing_VBG positive_JJ correlations_NNS of_IN fibrinogen_NN level_NN with_IN ponderal_JJ index_NN and_CC skinfolds_NNS in_IN both_DT Black_NP children_NNS and_CC White_JJ children_NNS ._SENT Similarly_RB ,_, Ferguson_NP et_FW al._FW (_( 30_CD Go_NP )_) in_IN a_DT study_NN of_IN 41_CD obese_JJ children_NNS found_VBD that_IN the_DT fibrinogen_NN level_NN was_VBD positively_RB associated_VBN with_IN the_DT percentage_NN of_IN body_NN fat_JJ ,_, subcutaneous_JJ adipose_JJ tissue_NN ,_, and_CC body_NN mass_NN index_NN ._SENT A_DT study_NN done_VBN in_IN Italy_NP (_( 29_NP Go_NP )_) also_RB found_VBD higher_JJR fibrinogen_NN levels_NNS in_IN obese_JJ compared_VBN with_IN nonobese_JJ children_NNS ._SENT Consistent_JJ with_IN these_DT studies_NNS ,_, we_PP previously_RB reported_VBD a_DT positive_JJ association_NN between_IN the_DT plasma_NN fibrinogen_NN level_NN and_CC measures_NNS of_IN obesity_NN ,_, namely_RB ,_, body_NN mass_NN index_NN ,_, sum_NN of_IN skinfolds_NNS ,_, and_CC subscapular/triceps_NNS ratio_NN in_IN children_NNS (_( 33_CD Go_NP )_) ._SENT In_IN adults_NNS ,_, the_DT Kuopio_NP Ischemic_NP Heart_NP Disease_NP Risk_NP Factor_NP Study_NP (_( 20_NP Go_NP )_) found_VBD an_DT inverse_NN graded_VBD relation_NN of_IN fibrinogen_NN with_IN physical_JJ activity_NN and_CC fitness_NN level_NN as_IN indicated_VBN by_IN maximal_JJ oxygen_NN (_( max_NN )_) uptake_NN ._SENT Later_RBR ,_, from_IN the_DT same_JJ population_NN ,_, Vaisanen_NP et_FW al._FW (_( 22_CD Go_NP )_) reported_VBD that_IN physical_JJ activity_NN and_CC cardiorespiratory_JJ fitness_NN were_VBD independent_JJ predictors_NNS of_IN fibrinogen_NN level_NN ,_, and_CC this_DT association_NN varied_VBD according_VBG to_TO fibrinogen_NN genotypes_NNS (_( TaqI_NP ,_, C/T[-148_NP ]_SYM ,_, and_CC BclI_NP )_) ._SENT Finally_RB ,_, lower_JJR fibrinogen_NN levels_NNS have_VBP been_VBN reported_VBN in_IN postmenopausal_JJ women_NNS with_IN higher_JJR levels_NNS of_IN physical_JJ activity_NN (_( 17_CD Go_NP )_) ._SENT This_DT association_NN remained_VBD after_IN adjustment_NN for_IN smoking_NN and_CC body_NN mass_NN index_NN ,_, among_IN other_JJ covariates_NNS ._SENT We_PP did_VBD not_RB observe_VB an_DT association_NN between_IN family_NN history_NN of_IN early_JJ onset_NN ischemic_JJ heart_NN disease_NN and_CC fibrinogen_NN level_NN in_IN children_NNS ._SENT Several_JJ other_JJ studies_NNS have_VBP reported_VBN such_PDT an_DT association_NN ._SENT Sanchez-Bayle_NP et_FW al._FW (_( 34_CD Go_NP )_) in_IN Spain_NP found_VBD higher_JJR fibrinogen_NN levels_NNS among_IN children_NNS with_IN a_DT positive_JJ family_NN history_NN of_IN cardiovascular_JJ disease_NN ,_, but_CC the_DT definition_NN of_IN family_NN history_NN in_IN that_DT study_NN included_VBD diabetes_NN and_CC stroke_NN as_RB well_RB as_IN myocardial_JJ infarction_NN ._SENT In_IN Greece_NP ,_, Rallidis_NP et_FW al._FW (_( 35_CD Go_NP )_) also_RB found_VBD higher_JJR plasma_NN fibrinogen_NN levels_NNS in_IN children_NNS of_IN men_NNS with_IN premature_JJ coronary_JJ heart_NN disease_NN ,_, and_CC this_DT association_NN remained_VBD after_IN adjustment_NN for_IN the_DT body_NN mass_NN index_NN of_IN the_DT children_NNS ._SENT In_IN our_PP$ study_NN ,_, the_DT small_JJ number_NN of_IN children_NNS with_IN a_DT positive_JJ family_NN history_NN may_MD have_VB precluded_VBN us_PP from_IN observing_VBG differences_NNS in_IN fibrinogen_NN level_NN in_IN relation_NN to_TO this_DT characteristic_NN ._SENT Nonetheless_RB ,_, we_PP included_VBD this_DT variable_NN in_IN multivariate_JJ models_NNS ,_, and_CC the_DT inverse_JJ associations_NNS between_IN fitness_NN and_CC plasma_NN fibrinogen_NN levels_NNS are_VBP adjusted_VBN for_IN family_NN history_NN ._SENT A_DT number_NN of_IN studies_NNS have_VBP reported_VBN an_DT association_NN between_IN cigarette_NN smoking_NN and_CC higher_JJR plasma_NN fibrinogen_NN level_NN in_IN adults_NNS (_( 25_CD Go_NP ,_, 28_CD Go_NP ,_, 41_NP Go_NP )_) ._SENT It_PP is_VBZ possible_JJ that_IN smoking_NN may_MD have_VB confounded_VBN our_PP$ findings_NNS if_IN children_NNS who_WP smoked_VBD were_VBD less_RBR fit_JJ ._SENT Since_IN we_PP do_VBP not_RB have_VB data_NNS on_IN smoking_NN habits_NNS ,_, we_PP cannot_MD address_VB this_DT possibility_NN directly_RB ._SENT However_RB ,_, Winkleby_NP et_FW al._FW (_( 42_CD Go_NP )_) recently_RB reported_VBD that_IN the_DT prevalence_NN of_IN smoking_NN in_IN children_NNS under_IN 13_CD years_NNS of_IN age_NN is_VBZ 1_CD percent_NN or_CC less_JJR ._SENT We_PP found_VBD the_DT same_JJ inverse_JJ association_NN between_IN physical_JJ fitness_NN and_CC plasma_NN fibrinogen_NN ,_, after_IN adjustment_NN for_IN measured_JJ covariates_NNS ,_, in_IN the_DT subgroup_NN of_IN 123_CD children_NNS under_IN age_NN 13_CD in_IN our_PP$ study_NN ._SENT It_PP therefore_RB appears_VBZ unlikely_JJ that_IN smoking_NN had_VBD a_DT significant_JJ confounding_VBG effect_NN in_IN our_PP$ main_JJ analysis_NN ._SENT A_DT second_JJ potential_JJ limitation_NN of_IN our_PP$ study_NN relates_VBZ to_TO the_DT complex_JJ recruitment_NN process_NN ._SENT We_PP explored_VBD the_DT potential_NN for_IN selection_NN bias_NN by_IN conducting_VBG analyses_NNS separately_RB for_IN children_NNS recruited_VBN from_IN high_JJ and_CC low_JJ risk_NN settings_NNS ._SENT The_DT results_NNS were_VBD similar_JJ in_IN both_DT groups_NNS ,_, although_IN statistical_JJ power_NN was_VBD limited_VBN in_IN this_DT subgroup_NN analysis_NN ._SENT Confirmatory_JJ multivariate_JJ analyses_NNS including_VBG a_DT term_NN for_IN this_DT variable_NN showed_VBD no_DT substantive_JJ effect_NN of_IN recruitment_NN setting_VBG on_IN the_DT magnitude_NN of_IN the_DT inverse_JJ association_NN of_IN fitness_NN with_IN fibrinogen_NN level_NN ,_, which_WDT also_RB remained_VBD statistically_RB significant_JJ in_IN these_DT analyses_NNS ._SENT Another_DT potential_JJ limitation_NN could_MD arise_VB from_IN the_DT exclusion_NN of_IN children_NNS who_WP did_VBD not_RB have_VB treadmill_NN testing_NN ._SENT However_RB ,_, we_PP chose_VBD the_DT single_JJ child_NN from_IN each_DT participating_VBG family_NN who_WP underwent_VBD treadmill_NN testing_NN in_IN a_DT systematic_JJ and_CC ,_, we_PP believe_VBP ,_, unbiased_JJ way_NN ,_, namely_RB ,_, the_DT oldest_JJS child_NN under_IN age_NN 25_CD ._SENT It_PP seems_VBZ unlikely_JJ that_IN this_DT selection_NN process_NN ,_, which_WDT occurred_VBD before_IN drawing_VBG or_CC analyzing_VBG blood_NN samples_NNS ,_, would_MD be_VB correlated_VBN systematically_RB with_IN plasma_NN fibrinogen_NN level_NN ._SENT Thus_RB ,_, these_DT exclusions_NNS are_VBP not_RB likely_JJ to_TO have_VB biased_VBN the_DT estimates_NNS of_IN association_NN between_IN physical_JJ fitness_NN and_CC plasma_NN fibrinogen_NN ._SENT In_IN addition_NN ,_, in_IN some_DT children_NNS who_WP underwent_VBD treadmill_NN testing_NN ,_, the_DT data_NNS were_VBD insufficient_JJ for_IN linear_JJ extrapolation_NN to_TO a_DT heart_NN rate_NN of_IN 170_CD beats_NNS per_IN minute_NN ,_, as_RB required_VBN by_IN the_DT PWC[170_NN ]_SYM protocol_NN (_( 16_CD Go_NP ,_, 36_NP Go_NP )_) ._SENT These_DT children_NNS were_VBD younger_JJR and_CC had_VBD a_DT lower_JJR body_NN mass_NN index_NN and_CC sum_NN of_IN skinfolds_NNS ,_, compared_VBN with_IN children_NNS included_VBN in_IN the_DT analyses_NNS ,_, and_CC their_PP$ mean_JJ fibrinogen_NN level_NN was_VBD lower_JJR ,_, although_IN this_DT difference_NN was_VBD not_RB statistically_RB significant_JJ ._SENT It_PP is_VBZ possible_JJ that_IN children_NNS who_WP achieved_VBD only_RB one_CD stage_NN of_IN the_DT protocol_NN ,_, and_CC thereby_RB were_VBD excluded_VBN ,_, were_VBD less_RBR fit_VBN than_IN those_DT who_WP completed_VBD two_CD or_CC more_JJR stages_NNS ._SENT The_DT sample_NN size_NN was_VBD not_RB large_JJ in_IN our_PP$ study_NN ,_, so_RB that_IN in_IN stratified_VBN analysis_NN ,_, the_DT number_NN of_IN children_NNS in_IN each_DT stratum_NN was_VBD relatively_RB small_JJ ,_, which_WDT may_MD explain_VB why_WRB the_DT trends_NNS observed_VBN did_VBD not_RB reach_VB significance_NN levels_NNS in_IN all_DT strata_NNS ._SENT Measurement_NN of_IN the_DT fitness_NN level_NN in_IN children_NNS is_VBZ challenging_VBG ._SENT While_IN we_PP used_VBD a_DT treadmill_NN protocol_NN that_WDT does_VBZ not_RB require_VB a_DT maximal_JJ effort_NN ,_, and_CC therefore_RB does_VBZ not_RB provide_VB a_DT direct_JJ measure_NN of_IN maximal_JJ oxygen_NN uptake_NN ,_, this_DT protocol_NN does_VBZ provide_VB an_DT estimate_NN of_IN aerobic_JJ fitness_NN that_WDT has_VBZ been_VBN shown_VBN in_IN other_JJ studies_NNS in_IN children_NNS to_TO be_VB associated_VBN with_IN other_JJ cardiovascular_JJ risk_NN factors_NNS including_VBG blood_NN pressure_NN and_CC lipid_NN levels_NNS (_( 9_CD Go_NP ,_, 13_CD Go_NP Go_NP Go_NP -16_NP Go_NP )_) ._SENT While_IN the_DT study_NN was_VBD cross-sectional_JJ in_IN design_NN ,_, it_PP is_VBZ unlikely_JJ that_IN the_DT fibrinogen_NN level_NN is_VBZ causally_RB antecedent_JJ to_TO physical_JJ fitness_NN ._SENT The_DT benefits_NNS of_IN exercise_NN and_CC physical_JJ fitness_NN on_IN the_DT incidence_NN of_IN cardiovascular_JJ disease_NN have_VBP been_VBN extensively_RB demonstrated_VBN in_IN adult_JJ populations_NNS (_( 6_CD Go_NP Go_NP -8_NP Go_NP )_) ._SENT There_EX are_VBP also_RB a_DT number_NN of_IN studies_NNS in_IN children_NNS showing_VBG a_DT relation_NN between_IN fitness_NN and_CC a_DT more_RBR favorable_JJ profile_NN of_IN cardiovascular_JJ risk_NN factors_NNS (_( 9_CD Go_NP Go_NP Go_NP Go_NP Go_NP Go_NP Go_NP -16_NP Go_NP )_) ,_, but_CC these_DT studies_NNS did_VBD not_RB include_VB the_DT fibrinogen_NN level_NN ._SENT How_WRB exercise_NN and_CC fitness_NN favorably_RB influence_VB cardiovascular_JJ risk_NN in_IN adults_NNS is_VBZ not_RB known_VBN ,_, but_CC it_PP has_VBZ been_VBN proposed_VBN that_IN one_CD mechanism_NN may_MD be_VB through_IN favorable_JJ effects_NNS on_IN the_DT plasma_NN fibrinogen_NN level_NN (_( 18_CD Go_NP Go_NP Go_NP Go_NP -22_NP Go_NP )_) ._SENT The_DT implications_NNS of_IN relative_JJ elevation_NN of_IN the_DT plasma_NN fibrinogen_NN level_NN in_IN childhood_NN for_IN adult_JJ risk_NN of_IN cardiovascular_JJ disease_NN are_VBP also_RB not_RB known_VBN ._SENT Our_PP$ findings_NNS indicate_VBP that_IN there_EX is_VBZ an_DT inverse_JJ association_NN during_IN childhood_NN between_IN fitness_NN ,_, as_RB indexed_VBN by_IN both_DT treadmill_NN testing_NN and_CC resting_JJ heart_NN rate_NN ,_, and_CC the_DT plasma_NN fibrinogen_NN level_NN ._SENT ACKNOWLEDGMENTS_NNS Supported_JJ by_IN grants_NNS HD-32195_NP ,_, RR-0645_NP ,_, and_CC PE-10012_NP ._SENT The_DT authors_NNS thank_VBP Dr._NP Dorit_NP Kaluski_NP ,_, Dr._NP Sarah_NP Couch_NP ,_, and_CC Dr._NP Abha_NP Kaistha_NP for_IN their_PP$ effort_NN in_IN recruiting_VBG subjects_NNS and_CC collecting_VBG the_DT data_NNS ;_: Sean_NP Mota_NP for_IN assistance_NN with_IN data_NN management_NN ;_: and_CC Dr._NP Steve_NP Humphries_NP and_CC Dr._NP Philippa_NP Talmud_NN for_IN their_PP$ helpful_JJ comments_NNS ._SENT NOTES_VBZ Reprint_NP requests_NNS to_TO Dr._NP Steven_NP Shea_NP ,_, Division_NP of_IN General_NP Medicine_NP ,_, Department_NP of_IN Medicine_NP ,_, College_NP of_IN Physicians_NPS and_CC Surgeons_NP of_IN Columbia_NP University_NP ,_, 622_CD West_NP 168th_NP Street_NP ,_, New_NP York_NP ,_, NY_NP 10032_CD (_( e-mail_NP :_: ss35{at}columbia.edu_NP )_) ._SENT REFERENCES_VBZ TOP_NP ABSTRACT_NP INTRODUCTION_NP MATERIALS_NP AND_CC METHODS_NP RESULTS_NP DISCUSSION_NP REFERENCES_NP 1_CD ._SENT Wilhemsen_NP L_NP ,_, Svardsudd_NP K_NP ,_, Korsan-Bengtsen_NP L_NP ,_, et_FW al._FW Fibrinogen_NN as_IN a_DT risk_NN factor_NN for_IN stroke_NN and_CC myocardial_JJ infarction_NN ._SENT N_NP Engl_NP J_NP Med_NP 1984_CD ;_: 311:501-5.[Abstract_NN ]_SYM 2_CD ._SENT Kannel_NP W_NP ,_, Wolf_NP P_NN ,_, Castelli_NP W_NP ,_, et_FW al._FW Fibrinogen_NP and_CC risk_NN of_IN cardiovascular_JJ disease_NN ._SENT The_DT Framingham_NP Study_NP ._SENT JAMA_NP 1987_CD ;_: 258:1183-6.[Abstract_NN ]_SYM 3_CD ._SENT Folsom_NP AR_NP ,_, Wu_NP KK_NP ,_, Rosamond_NP WD_NP ,_, et_FW al._FW Prospective_JJ study_NN of_IN hemostatic_JJ factors_NNS and_CC incidence_NN of_IN coronary_JJ heart_NN disease_NN :_: the_DT Atherosclerosis_NN Risk_NN in_IN Communities_NNS (_( ARIC_NP )_) Study_NP ._SENT Circulation_NN 1997_CD ;_: 96:1102-8.[Abstract/Free_JJ Full_JJ Text_NN ]_SYM 4_CD ._SENT Heinrich_NP J_NP ,_, Balleisen_NP L_NP ,_, Schulte_NP H_NP ,_, et_FW al._FW Fibrinogen_NP and_CC factor_VB VII_NP in_IN the_DT prediction_NN of_IN coronary_JJ ri_NNS 